As of Oct 20
| -0.07 / -0.40%|
The 3 analysts offering 12-month price forecasts for AngioDynamics Inc have a median target of 17.00, with a high estimate of 20.00 and a low estimate of 16.00. The median estimate represents a -3.52% decrease from the last price of 17.62.
The current consensus among 5 polled investment analysts is to Hold stock in AngioDynamics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.